key: cord-0781876-xtmuc13t authors: Mendel, Julian; Frank, Kelvin; Edlin, Lourdes; Hall, Kelley; Webb, Denise; Mills, John; Holness, Howard K.; Furton, Kenneth G.; Mills, DeEtta title: Preliminary accuracy of COVID-19 odor detection by canines and HS-SPME-GC-MS using exhaled breath samples date: 2021-06-09 journal: Forensic Sci Int Synerg DOI: 10.1016/j.fsisyn.2021.100155 sha: 811adafe2448fe5f948c89d97184781a440d8a85 doc_id: 781876 cord_uid: xtmuc13t The novel coronavirus SARS-CoV-2, since its initial outbreak in Wuhan, China has led to a worldwide pandemic and has shut down nations. As with any outbreak, there is a general strategy of detection, containment, treatment and/or cure. The authors would argue that rapid and efficient detection is critical and required to successful management of a disease. The current study explores and successfully demonstrates the use of canines to detect COVID-19 disease in exhaled breath. The intended use was to detect the odor of COVID-19 on contaminated surfaces inferring recent deposition of infectious material from a COVID-19 positive individual. Using masks obtained from hospitalized patients that tested positive for COVID-19 disease, four canines were trained and evaluated for their ability to detect the disease. All four canines obtained an accuracy >90% and positive predictive values ranging from ∼73 to 93% after just one month of training. decontamination chamber (Dosage >500 mj/cm 2 ) (Air Science USA LLC. Fort Myers, 123 FL). Additionally, samples were allowed to sit for 24-72 hours before being presented to 124 a canine, thus adding an additional layer of safety as it has been shown the virus 125 viability rapidly declines within hours to days (46). 126 127 128 To ensure that UV radiation did not affect the VOCs, a prior analysis of pre-and post-130 UV treated samples, using headspace solid phase microextraction gas chromatography 131 mass spectrometry (HS-SPME-GC-MS), was conducted with a mixture of common 132 human scent VOCs. A 50µl aliquots of a compound mix was pipetted onto separate 1-133 inch x 1-inch pieces of masks (n=12), half of which were subjected to UV radiation. The Chemical analysis of patient masks using HS-SPME-GCMS 147 An analysis of the VOCs from the PPE samples (masks previously worn by patients) 148 was conducted utilizing headspace sampling with solid phase microextraction followed 149 by analysis by gas chromatography mass spectrometry (HS-SPME-GCMS). After 150 irradiating masks for 10 minutes, 1" x 1" portions were cut and fitted into 40ml 151 headspace vials. Samples were heated at 40ºC and extracted for 15 hours utilizing a 152 DVB/CAR/PDMS SPME fiber. After extraction, the fibers were then injected in to the 153 GCMS for analysis. training runs were completed, and the accuracy and positive predictive value of the 220 canines was calculated. In addition, 40 double blind trials were conducted to evaluate 221 canine performance training (Table 4) . A summary of the training parameters and 222 double-blind trials can be seen in Table 1 . Canines were exposed to 24 different 223 positive patient masks during the study and 10 COVID-19 negative, but sick patient 224 masks. A total of four training aids were made from each mask and only one positive Canine Training 275 Of the 221 training runs using COVID-19 samples, the first 96 training sessions (Table 276 2.) utilized negative controls or distractors from sick patients in the hospital that had a 277 negative rtPCR test for COVID-19 but had other illnesses. Overall, the accuracy 278 obtained by the four canines using those negative controls was 85.2% while the positive 279 predictive value was 64.0%, respectively. Specific accuracy and positive predictive 280 responses for each canine from the first three weeks of the COVID-19 training were as 281 follows: Mac 80% and 59%, Cobra 81% and 65%, One Betta 96% and 73% and Hubble 282 84% and 59% (Table 2) . 283 In subsequent test scenarios with 121 runs, the COVID-19 positive targets were again 293 presented to the canines, but unused clean blank masks were used as negative targets. 294 The average accuracy and positive predictive value for these sessions increased to 295 98.8% and 86.8%, respectively, with Mac 93.9% and 73.7%, Cobra 96.2% and 93.9%, 296 One Betta 96.6% and 91.3% and Hubble 97.0% and 88.9% (Table 3) . 297 298 The outbreak of COVID-19: An overview Weekly epidemiological update The Global Economic Outlook During the COVID-19 Pandemic: A Changed 457 World Impact of the coronavirus pandemic on the global economy -Statistics & Facts | 461 Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR Chest CT Features of COVID-19 in 472 Systematic review with meta-analysis of the accuracy of diagnostic tests for 473 COVID-19 Detection of volatile organic compounds (VOCs) from 480 exhaled breath as noninvasive methods for cancer diagnosis Umasankar; N. Pala; S. Bhansali, 486 Prospects and challenges of volatile organic compound sensors in human 487 healthcare Non-489 volatile compounds in exhaled breath condensate: review of methodological 490 aspects Evolution of clinical and environmental health 492 applications of exhaled breath research: Review of methods and instrumentation 493 for gas-phase, condensate, and aerosols Volatolomics: A broad area of 495 experimentation Use of electronic noses for diagnosis of 497 digestive and respiratory diseases through the breath Volatile organic compounds as 501 biomarkers of gastrointestinal diseases and nutritional status Recent advances in breath analysis 504 to track human health by new enrichment technologies Breath acetone sensors as non-invasive 507 health monitoring systems: A review Current challenges in volatile organic compounds 509 analysis as potential biomarkers of cancer The fluid dynamics of canine olfaction: 512 Unique nasal airflow patterns as an explanation of macrosmia The scientific foundation and efficacy of the use of 522 canines as chemical detectors for explosives Trained dogs outperform human 525 surveyors in the detection of rare spotted knapweed Ability of canine termite detectors to locate 528 live termites and discriminate them from non-termite material 537 Differentiation of toxic molds via headspace SPME-GC/MS and canine detection Are wildlife detector dogs or people better at finding Desert 541 Tortoises (Gopherus agassizii)? Ability of bed bug-detecting canines to 543 locate live bed bugs and viable bed bug eggs 546 Diagnostic accuracy of canine scent detection in early-and late-stage lung and 547 breast cancers, Integr. Cancer Ther Canine scent detection in the diagnosis of lung cancer: Revisiting a 553 puzzling phenomenon Canine 557 olfaction and electronic nose detection of volatile organic compounds in the 558 detection of cancer: A Review Canine detection of 561 the volatilome: A review of implications for pathogen and disease detection, 562 Front The Investigation of Human Scent from Epileptic Patients for the 564 Identification of a Biomarker for Epileptic Seizures Using canines for earlier detection of laurel wilt disease affecting 568 avocado trees in South Florida An evaluation of scent-discriminating canines 571 for rapid response to agricultural diseases Canine olfactory detection of a vectored phytobacterial pathogen Liberibacter asiaticus, and integration with disease control Canine olfactory detection of a non-systemic phytobacterial citrus 580 pathogen of international quarantine significance Scent dog identification of samples 585 from COVID-19 patients -A pilot study Can the detection dog alert on COVID-19 positive persons by sniffing 595 axillary sweat samples? A proof-of-concept study Ultraviolet irradiation doses for 598 coronavirus inactivation -review and analysis of coronavirus photoinactivation 599 studies Controlled odor mimic permeation system Controlled 605 Odor Mimic Permeation Systems for Olfactory Training and Field Testing Comparison of the volatile 610 organic compounds present in human odor using SPME-GC/MS Longitudinal Monitoring of 614 SARS-CoV-2 RNA on High-Touch Surfaces in a Community Setting Persistent Symptoms in Patients After Acute 617 COVID-19 Naturalistic quantification of canine olfactory sensitivity declare the following financial interests/personal relationships which may be considered as potential competing interests as unused masks. The recorded ranges were 96.2%-99.4% (ACC) and 87%-97.6% 367 (PPV). 368 369 PPV is perhaps a stronger indicator of success as it takes into consideration the number 370 of false positive alerts and is an indicator of how sure that one can be if a dog does alert 371 when COVID-19 odor is, in fact, present, and the challenge when working with any 372 biological samples has to be mentioned. In general, there are a number of potential 373 confounding factors, primarily the fact that the disease system is in constant flux, or is 374 dynamic, and at different points in the disease, metabolic changes are possible that 375 may, in turn, alter the VOC profile being detected. With respect to human disease, there 376 are a number of conditions, and health status questions that can be raised, one major 377 question raised by the authors for future studies is how COVID-19 odors presents itself 378 in asymptomatic patients versus those with symptoms. This study was unable to control 379 for pre-existing conditions, age, gender, diet etc. as the masks were randomly acquired 380 from positive and negative COVID-19 patients. Due to the urgency of the study and a 381 lack of IRB approval to conduct research that would involve patient data, useful metrics 382 such as patient symptom status, age, underlying health conditions etc., were not 383 obtained and will be a consideration for future studies. One issue encountered with the 384 study was the fact that initial training took place using PCR negative patient masks as 385 non-targets. The lower ACC and PPV presented for this portion of the training could be 386 attributed to: (a) the dogs were early in their training, (b) breath VOCs were very similar 387 to COVID-19 as these patients presented at the hospital because they were ill, or (c) the 388 patients had tested negative and were asymptomatic, but those data were not available 389 to decipher how long a person's metabolism, the origin of the VOCs, remains "COVID-417 like" even after they test negative for the viral load. In other words, the body's 418 metabolism may not recover as rapidly as the decrease in viral load, as evidenced by 419 the 'long haulers' that continue to have persistent symptoms, including respiratory 420complications. In an Italian study that followed patients for 60 days after acute 421 symptoms were recorded, 55.2% of the 143 patients in the study, reported having > 3 422 persistent symptoms, 32.2 % reported they were experiencing 1-2 symptoms while 12.6 423 % felt no symptoms (52). It is of interest to analyze the breath samples from these 424individuals to see what the odor 'decay' curve may indicate. If this is the case, then the 425 areas to which the canines alerted may indicate that even though the person has tested 426 negative after infection, the metabolism has not returned to pre -COVID 19 levels, and 427 the canines are still able to recognize the disease-specific volatilome. And, one must 428 keep in mind, canine olfaction capabilities have often been shown to be more sensitive 429 than the lower level of instrumental detection (53). While ongoing studies will help 430 answer some of these questions, this study has shown that, with a high degree of 431 accuracy, canines, trained to recognize COVID-19 odor profiles, can provide one more 432 tool, one more layer of protection, that can be utilized in the fight to dampen and